切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2013, Vol. 07 ›› Issue (03) : 170 -173. doi: 10.3877/cma.j.issn.1647-0793.2013.03.002

所属专题: 文献

论著

奥曲肽对人结肠癌细胞生长增殖抑制作用的研究
龙建武1, 梁庆模2,(), 李峰1, 刘龙飞1, 周筱筠1, 卢先洲1   
  1. 1. 421002 衡阳,南华大学附属南华医院胃肠外科
    2. 南华大学附属第一医院肿瘤外科
  • 收稿日期:2013-03-12 出版日期:2013-06-01
  • 通信作者: 梁庆模
  • 基金资助:
    湖南省自然科学基金资助项目(07JJ6158)

Study of proliferation inhibition of octreotide on colonic cancer cells

Jian-wu LONG1, Qing-mo LIANG2,(), Feng LI1, Long-fei LIU1, Xiao-jun ZHOU1, Xian-zhou LU1   

  1. 1. Department of Gastrointestinal Surgery, the Affiliated Nanhua Hospital of University of South China, Hengyang 421002, China
  • Received:2013-03-12 Published:2013-06-01
  • Corresponding author: Qing-mo LIANG
  • About author:
    Corresponding author: LIANG Qing-mo, Email:
引用本文:

龙建武, 梁庆模, 李峰, 刘龙飞, 周筱筠, 卢先洲. 奥曲肽对人结肠癌细胞生长增殖抑制作用的研究[J/OL]. 中华普通外科学文献(电子版), 2013, 07(03): 170-173.

Jian-wu LONG, Qing-mo LIANG, Feng LI, Long-fei LIU, Xiao-jun ZHOU, Xian-zhou LU. Study of proliferation inhibition of octreotide on colonic cancer cells[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(03): 170-173.

目的

研究不同浓度的生长抑素类似物奥曲肽对人结肠癌SW480细胞生长增殖的抑制作用。

方法

体外培养人结肠癌SW480细胞,MTT比色法测定不同浓度奥曲肽抑制SW480细胞增殖作用,以效价强度最高者为最佳抑制浓度;平皿集落形成法测定奥曲肽抑制体外培养SW480细胞的锚定依赖性生长作用。

结果

不同浓度奥曲肽对SW480细胞增殖活性具有不同程度的抑制作用,在1×10-10~1×10-8 mol/L浓度范围内呈剂量依赖性,其中1×10-8 mol/L为最佳抑制浓度;奥曲肽对SW480细胞锚定依赖性生长具有明显的抑制作用,并呈浓度依赖性。

结论

奥曲肽能抑制体外培养的人结肠癌SW480细胞生长增殖,并在一定范围内呈浓度与时间依赖性。

Objective

To study the effect of somatosatin analogue octreotide at different concentrations on proliferation in colonic cancer cell line SW480.

Methods

To cultivate colon cancer SW480 cell in vitro, MTT assay was used to analyze the effect of octreotide at different concentrations on the proliferation of SW480 cell. The best inhibiting concentration was screened which had the maximum potency. Colony formation assay on plate was used to test inhibition of clone formation in SW480 cells by octreotide(OCT).

Results

Different concentrations of OCT inhibited the proliferation of SW480 cells, in dose and time-dependent manner during the concentrations of OCT(1×10-10 to 1×10-8 mol/L), and the inhibitory effect of octreotide at 1×10-8 mol/L was the most significant. Colony formation assay on plate showed that octreotide significantly inhibited the anchorage dependent growth of SW480 cells in a concentration-dependent manner.

Conclusion

OCT causes inhibition of colonic cancer cell line SW480 growth and proliferation, and the effect was dose and time dependent to a certain degree.

表1 奥曲肽对人结肠癌SW480细胞增殖抑制作用(±s, n=6)
图1 奥曲肽对SW480细胞增殖抑制作用
图2 奥曲肽抑制人结肠癌SW480细胞锚定依赖性生长
1
Tejeda M, Gaal D, Hullan L, et al. Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models. Anticancer Res, 2006, 26(5A): 3477-3483.
2
Tsagarakis NJ, Drygiannakis I, Batistakis AG, et al. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol, 2011, 17(3): 313-321.
3
Ma Q, Meng LQ, Liu JC, et al. Octreotide induces apoptosis of human hepatoma cells by the mechanism of facilitating the Fas/FasL gene expression therein. Zhonghua Yi Xue Za Zhi, 2008, 88(10): 716-718.
4
李义生,王书奎,王和明, 等. 术前联合奥曲肽行淋巴化疗对大肠癌的治疗研究[J/CD]. 中华临床医师杂志:电子版, 2012, 6(11): 3121-3122.
5
Ferrante E, Pellegrini C, Bondioni S, et al. Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2. Endocr Relat Cancer, 2006, 13(3): 955-962.
6
Tagliati F, Zatelli MC, Bottoni A, et al. Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro. Endocrinology, 2006, 147(7): 3530-3538.
7
王松,包铮,龙建武, 等. APC/β-catenin/TCF通路在奥曲肽调控结肠癌SW480细胞中的分子机制. 世界华人消化杂志, 2010, 36(6): 3857-3862.
8
Chen JS, Liang QM, Long JW, et al. Octreotide inhibits growth of colonic cancer SW480cells by modulating the Wnt/β-catenin pathway. Pharmazie, 2009, 64(2): 126-131.
9
Lock FE, Underhill-Day N, Dunwell T, et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene, 2010, 29(30):4307-4316.
10
Bikkavilli RK, Malbon CC. Mitogen-activated protein kinases and Wnt/β-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol. 2009, 2(1): 46-49.
11
Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature, 2005, 434(7035): 843-850.
12
Meijer L, Flajoet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci, 2004, 25(9): 471-480.
13
Parry JJ, Eiblmaier M, Andrews R, et al. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Mol Imaging, 2007, 6(1): 56-67.
14
Siriwardana G, Bradford A, Coy D, et al. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol, 2006, 20(9): 2010-2019.
15
Theodoropoulou M, Zhang J, Laupheimer S, et al. Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zacl expression. Cancer Res, 2006, 66(3): 1576-1582.
16
Shi CS, Huang NN, Harrison K, et al. The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes. Mol Cell Biol, 2006, 26(17): 6511-6521.
[1] 郭仁凯, 武慧铭, 李辉宇. 机器人辅助全系膜切除术治疗右半结肠癌有效性和安全性的Meta分析及试验序贯分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 234-240.
[2] 聂彬, 赵铁军, 于云宝, 李欢, 谢林峻. 单孔加一孔腹腔镜手术与传统腹腔镜手术治疗乙状结肠癌的疗效与分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 330-333.
[3] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[4] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[5] 陆思楠, 苏同荣, 张启逸. 索凡替尼转化治疗胰腺神经内分泌肿瘤肝转移一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 526-530.
[6] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[7] 杨魁, 龚文斌, 余钧辉, 郑见宝, 孙学军, 赵伟. 腹部无辅助切口经阴道拖出标本的腹腔镜右半结肠癌根治术一例(附视频)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(02): 171-176.
[8] 连彦军, 宋志岗, 范晓斌, 胡延伟, 范现英, 马竞优, 甄金朋, 杨宁豹. 肠减压后腹腔镜手术治疗右半结肠癌合并急性肠梗阻的临床观察[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(02): 129-134.
[9] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[10] 赵文元, 田玉廷, 张吉海, 张军. CT肿瘤体积测量参数结合实验室指标对结肠癌术前分期预判的价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 306-309.
[11] 周庆, 杨旭. 甲胎蛋白、纤维蛋白原与前白蛋白比值、癌胚抗原、D-二聚体对结肠癌术后复发的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 301-305.
[12] 曹猛, 郭杰东, 朱灿, 许腾, 樊瑞智, 江涛, 宋军, 徐溢新. 完全腹腔镜右半结肠切除术中顺蠕动侧侧吻合的有效性及安全性评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 315-319.
[13] 谢鸿, 李娜, 李尚日, 谢涛. 肠道菌群特征对结肠癌化学治疗疗效的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 53-56.
[14] 武文晓, 张大奎, 孙志刚, 韩子翰, 陈少轩, 侯智勇, 孙白龙, 介建政. pMMR/MSS型结肠癌免疫治疗效果及预后标志物研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 41-56.
[15] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析:附5例报告[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
阅读次数
全文


摘要